RLF.SW
RELIEF THERAPEUTICS Holding SA
Price:  
3.75 
CHF
Volume:  
45,034.00
Switzerland | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RLF.SW WACC - Weighted Average Cost of Capital

The WACC of RELIEF THERAPEUTICS Holding SA (RLF.SW) is 6.7%.

The Cost of Equity of RELIEF THERAPEUTICS Holding SA (RLF.SW) is 6.85%.
The Cost of Debt of RELIEF THERAPEUTICS Holding SA (RLF.SW) is 5.00%.

Range Selected
Cost of equity 5.40% - 8.30% 6.85%
Tax rate 9.90% - 17.30% 13.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.4% - 8.0% 6.7%
WACC

RLF.SW WACC calculation

Category Low High
Long-term bond rate 1.0% 1.5%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.29 0.55
Additional risk adjustments 3.0% 3.5%
Cost of equity 5.40% 8.30%
Tax rate 9.90% 17.30%
Debt/Equity ratio 0.09 0.09
Cost of debt 5.00% 5.00%
After-tax WACC 5.4% 8.0%
Selected WACC 6.7%